Peptide Purity by HPLC: How It's Calculated

HPLC purity for a peptide is the percentage of the total chromatogram area that belongs to the main peak. If the target peptide accounts for 99.3% of all integrated area and the remaining peaks sum to 0.7%, the reported purity is 99.3%. The formal name for this figure is normalized area percent — the standard method analytical laboratories use when issuing a certificate of analysis (CoA) for a research peptide lot.

How the analysis works

A small aliquot of the dissolved sample is injected into a chromatographic column. The mobile phase carries it through, and components separate according to their differential affinity for the stationary phase. Synthesis impurities — truncated sequences, deletion peptides, deprotection byproducts — elute at different retention times than the target compound and emerge as distinct peaks.

A UV detector measures absorbance as each component exits the column. For peptides, the detector is set to 215–220 nm, the range where the peptide bond absorbs. That wavelength responds to any fragment carrying peptide structure, not only to the target compound — which is precisely what makes it useful for detecting synthesis impurities across an entire lot.

The output is a chromatogram: absorbance plotted against retention time. Each peak represents one component of the mixture.

The area percent calculation

The instrument's software integrates the area under each peak. The formula is:

Purity (%) = (area of the main peak ÷ sum of all peak areas) × 100

A main peak with 993 area units and all other peaks summing to 7 gives (993 ÷ 1000) × 100 = 99.3%. No external calibration curve is needed because this is a relative measurement: what fraction of the total integrated absorbance belongs to the peak of interest. That also means the method works when no certified reference standard exists for the specific compound.

What impurities appear most often

Solid-phase peptide synthesis (SPPS) generates two main categories of impurities:

• Truncated or deleted sequences. Each amino acid coupling step is never fully quantitative. A 20-residue peptide synthesized at 98.5% coupling efficiency per step accumulates byproducts that no post-synthesis purification removes entirely.
• Deprotection byproducts. Protecting groups are removed in a single cleavage step at the end of synthesis. Traces of those byproducts can persist in the finished lot.

Both categories elute at different times than the target peptide and appear as separate peaks in the chromatogram. That separation is what makes them countable.

What ≥99% HPLC means in practice

A peptide declared at 99.0% HPLC purity contains 1% of material other than the target compound, distributed across all minor peaks. That fraction may include synthesis fragments — but also water of crystallization, counterions from the purification process, or byproducts that do not absorb at 215 nm.

The last category is the method's structural boundary. Normalized area percent measures precisely what the UV detector detects. Materials that do not absorb at the working wavelength — water, inorganic salts, most counterions — are invisible to the detector and do not enter the denominator. A lot could carry inorganic content that does not appear anywhere in the chromatogram.

For a laboratory working with a well-characterized compound, HPLC purity is the reference parameter for peptide synthesis impurities. Complementary methods — Karl Fischer titration for water content, mass spectrometry for molecular identity confirmation, elemental analysis for inorganic impurities — complete the picture when the application requires it.

PeptoClinic supplies research peptides at ≥99% HPLC purity, verified by an independent laboratory. The Retatrutide and MOTS-c lots analyzed by Janoshik Analytical in April 2026 returned 99.893% and 99.669% respectively. The lower figure — 99.669% — is the floor for what has been dispatched from this catalogue, and it is the number that describes the line honestly rather than the one that reads better in a heading.

How to read a certificate of analysis

A useful HPLC purity CoA includes at minimum:

• Compound name and lot number
• Chromatographic conditions: column, mobile phase composition, gradient, detector wavelength
• Retention time of the main peak
• Area percent of the main peak
• The chromatogram itself, or a direct reference to where it can be retrieved
• Analysis date and analyst identifier or signature

What should not be accepted as purity evidence: a number in a table with no chromatogram attached, a PDF with no date and no identified laboratory, a screenshot with no reference to the specific sample analyzed.

Janoshik Analytical reports include a verifiable task number, the chromatogram and the full spectrum. The four lots analyzed for PeptoClinic are linked from the PeptoClinic quality page, where each report can be opened directly. If a supplier cannot produce the chromatogram that generated their number, that number is unverified.

Conditions that change the reading

The same lot can return different figures under different analytical conditions. Three factors account for most of the variation.

Mobile phase gradient. A slower gradient resolves impurities that elute close to the main peak. A fast gradient can merge an adjacent shoulder into the main peak, leaving those impurities uncounted and the reported purity inflated.

Detector wavelength. At 215 nm the detector responds to nearly any peptide-containing structure. At 280 nm it responds only to aromatic residues such as tryptophan and tyrosine. A peptide without those residues, analyzed at 280 nm, produces a low or null signal — analytically useless as a sole purity measure for the vast majority of research peptides.

Column temperature. Temperature affects chromatographic separation and shifts retention times. Conditions must be recorded in the report for the analysis to be reproducible and interpretable by a third party.

A CoA that reports only the number without documenting the conditions under which it was produced is a partial document.

Research use only

The peptides analyzed by HPLC and supplied by PeptoClinic are designated strictly for Research Use Only (RUO): in vitro and laboratory work.

This material is not approved for human or veterinary use. It is not a medicine, a supplement or a consumer product. No claim on this site has been evaluated by the FDA, ANMAT or any equivalent authority. PeptoClinic is not a pharmacy, a clinic or a source of dosing or administration guidance.

Research programmes that need material with documented purity for in vitro applications can review the PeptoClinic catalogue or write to [email protected] to request a quote.